Investigating heart health in young cancer survivors
Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors
This study is looking at how cancer treatments might impact heart health in young people aged 15-39 who have survived cancer, to find out which survivors may be at greater risk for heart problems later on.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10978773 on NIH RePORTER |
What this research studies
This research focuses on understanding how cancer treatments affect heart health in adolescents and young adults (AYAs) aged 15-39 who have survived cancer. It aims to identify signs of accelerated cardiac aging in these patients, particularly those who have received cardiotoxic treatments. By examining biological markers of aging and their relationship to heart function, the study seeks to determine which survivors are at the highest risk for cardiovascular issues. The research will involve a diverse group of 1,200 AYA cancer survivors to ensure comprehensive insights.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 15-39 who have survived cancer and received cardiotoxic treatments.
Not a fit: Patients who are not cancer survivors or those who have not undergone cardiotoxic cancer treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and treatment strategies for heart health in young cancer survivors.
How similar studies have performed: Previous research has shown that similar approaches to studying cardiac health in cancer survivors have yielded valuable insights, indicating potential for success in this area.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Hildebrandt, Michelle a T — University of Tx Md Anderson Can Ctr
- Study coordinator: Hildebrandt, Michelle a T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.